Randomized, Controlled Multicenter Trial Demonstrates Safety and Clinical Benefit, Significant Reduction in Repeat Surgeries Enabled by Dune’s MarginProbe™.

Company Opens US Office to Spearhead North American Operations Caesarea, Israel-Jan. 7, 2008 – Dune Medical Devices announces significant new clinical developments surrounding the company’s novel breast cancer assessment probe, currently in investigational use. Results from a recent randomized clinical…

Read More
- Enter Your Location -
- or -